Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer.
Journal: JAMA otolaryngology-- head & neck surgery
Published: April 02, 2026
Comment on: Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Head & neck
Published: December 12, 2025
Circulating Human Papillomavirus DNA-Liquid Biopsy in Head and Neck Cancers.
Journal: Journal of medical virology
Published: July 06, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 10, 2025
Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial.
Journal: American journal of clinical oncology
Published: April 08, 2025
Patient Characteristics and Treatment Outcomes of Nasopharyngeal Carcinoma in Nonendemic Regions.
Journal: JAMA network open
Published: March 26, 2025
Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance status.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 23, 2025
Predictors of brachial plexopathy following head and neck reirradiation.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 21, 2024
Novel combinations with programmed cell death 1 inhibitor for incurable recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC): is cabozantinib a front runner?
Journal: Translational cancer research
Published: December 17, 2024
Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab.
Journal: Cancer immunology, immunotherapy : CII
Published: December 14, 2024
Weekly Cisplatin Cycles and Outcomes for Chemoradiation in Head and Neck Cancer.
Journal: JAMA network open
Published: December 09, 2024
Last Updated: 09/26/2026